Gov’t to construct ‘one-stop’ diabetes centre – Anthony
The Ministry of Health will build a one-stop diabetes center to give people with diabetes better control over the disease.Health Minister Dr. Frank...
Fierce Pharma Asia—AstraZeneca-Junshi PD-1 deal; Takeda’s $1.2B diabetes selloff, Ovid epilepsy collab pullout
In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...
Tandem Diabetes Care Inc. (TNDM) Soars 3.97% on March 05
Market overview
consequences
Tandem Diabetes Care Inc. is a medical device company that develops products for people with insulin-dependent diabetes. The company has...
Diabetes sort 2: Food plan and train can scale back your threat of the...
Type 2 diabetes is more common in people who are overweight, according to the National Institute for Diabetes and Digestive and Kidney Diseases (NIH)....
Lilly’s tirzepatide results in physique weight reductions in sort 2 diabetes trial
Eli Lilly and Company reported...
Nationwide Kidney Basis Acknowledges Nationwide Kidney Month by Specializing in Diabetes
In honor of National Kidney Month, which begins today, the National Kidney Foundation (NKF) National Public Awareness Campaign: "Are You the 33%?" enters a...
Section III Trial Reveals Lilly’s Tirzepatide is Superior to Rival in Kind 2 Diabetes
Jonathan Weiss / Shutterstock
Eli Lillys The Phase III SURPASS 2 clinical trial shows treatment with tirzepatide, a once-weekly dual glucose-dependent insulinotropic polypeptide and glucagon-like...